Payment overview · 2025
General Payments
$54,317.75
90 reported records · 26 companies
Healthcare provider profile · identity verified
Brian David Lepow, DPM
Podiatric Medicine & Surgery Service Providers|Podiatrist|Foot & Ankle Surgery · HOUSTON, TX · NPI 1124286216
Verified facts
What the public records show
CMS Open Payments records show Brian David Lepow, DPM received $54,317.75 in general payments during 2025 across 90 reported records.
Stryker Corporation accounted for 64.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 39 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $35,141.22 | 64.7% | 30 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $6,138.89 | 11.3% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $3,455.58 | 6.4% | 5 | 2025 |
| Gunze International USA, Inc. | Unresolved — no canonical attribution shown | $2,500.00 | 4.6% | 1 | 2025 |
| LifeNet Health | Unresolved — no canonical attribution shown | $2,382.42 | 4.4% | 5 | 2025 |
| ETS Wound Care LLC | Unresolved — no canonical attribution shown | $1,811.50 | 3.3% | 8 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $1,208.90 | 2.2% | 6 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $637.17 | 1.2% | 4 | 2025 |
| ASAHI INTECC USA, INC. | Unresolved — no canonical attribution shown | $226.11 | 0.4% | 2 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $114.99 | 0.2% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $106.32 | 0.2% | 4 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $85.56 | 0.2% | 2 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $64.02 | 0.1% | 2 | 2025 |
| Veryan Medical Incorporated | Unresolved — no canonical attribution shown | $55.55 | 0.1% | 1 | 2025 |
| Acera Surgical, Inc. | Unresolved — no canonical attribution shown | $53.51 | 0.1% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $51.72 | 0.1% | 3 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $47.65 | 0.1% | 2 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $32.63 | 0.1% | 1 | 2025 |
| Access Pro Medical, LLC | Unresolved — no canonical attribution shown | $32.12 | 0.1% | 1 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $32.07 | 0.1% | 2 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $26.07 | 0.1% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $25.44 | 0.1% | 1 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $25.07 | 0.1% | 1 | 2025 |
| Aroa Biosurgery Incorporated | Unresolved — no canonical attribution shown | $21.74 | 0.0% | 1 | 2025 |
| Reprise Biomedical, Inc. | Unresolved — no canonical attribution shown | $21.16 | 0.0% | 1 | 2025 |
| Urgo Medical North America, LLC | Unresolved — no canonical attribution shown | $20.34 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $32,650.00 | 15 |
| Long term medical supply or device loan | $6,138.89 | 1 |
| Travel and Lodging | $6,121.19 | 10 |
| Food and Beverage | $3,314.87 | 57 |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,500.00 | 1 |
| Honoraria | $2,500.00 | 1 |
| Education | $1,092.80 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $36,048.10 | 28 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $36,048.10 | 28 | 2025 |
Source payment records
|
|||||
| Auryon Laser System 100-120 Vac Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $6,138.89 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $3,455.58 | 5 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $3,455.58 | 5 | 2025 |
Source payment records
|
|||||
| PELNAC Wound Matrix Normalized: pelnac wound matrix |
Device | Gunze International USA, Inc. | $2,500.00 | 1 | 2025 |
Source payment records
|
|||||
| TheraGenesis Wound Matrix Normalized: theragenesis wound matrix |
Device | LifeNet Health | $2,382.42 | 5 | 2025 |
Source payment records
|
|||||
| MIRRAGEN ADVANCED WOUND MATRIX Normalized: mirragen advanced wound matrix |
Device | ETS Wound Care LLC | $1,811.50 | 8 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $609.25 | 3 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $609.25 | 3 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $302.02 | 8 | 2025 |
Source payment records
|
|||||
| Asahi Peripheral Vascular Wires Normalized: asahi peripheral vascular wires |
Device | ASAHI INTECC USA, INC. | $226.11 | 2 | 2025 |
Source payment records
|
|||||
| ROSEN Normalized: rosen |
Device | Cook Medical LLC | $95.41 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $84.45 | 3 | 2025 |
Source payment records
|
|||||
| BioMimics 3D Vascular Stent System Normalized: biomimics 3d vascular stent system |
Device | Veryan Medical Incorporated | $55.55 | 1 | 2025 |
Source payment records
|
|||||
| Restrata Wound Matrix Normalized: restrata wound matrix |
Device | Acera Surgical, Inc. | $53.51 | 2 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $47.65 | 2 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $47.65 | 2 | 2025 |
Source payment records
|
|||||
| GRAFIX PL Normalized: grafix pl |
Biological | Smith+Nephew, Inc. | $45.20 | 1 | 2025 |
Source payment records
|
|||||
| STRAVIX PL Normalized: stravix pl |
Biological | Smith+Nephew, Inc. | $45.20 | 1 | 2025 |
Source payment records
|
|||||
| RENASYS TOUCH Normalized: renasys touch |
Device | Smith+Nephew, Inc. | $40.36 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $32.63 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $32.63 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $32.63 | 1 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $32.63 | 1 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $32.63 | 1 | 2025 |
Source payment records
|
|||||
| MATRIDERM Normalized: matriderm |
Device | Access Pro Medical, LLC | $32.12 | 1 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $32.07 | 2 | 2025 |
Source payment records
|
|||||
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $27.92 | 1 | 2025 |
Source payment records
|
|||||
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $26.07 | 1 | 2025 |
Source payment records
|
|||||
| AFFINITY Normalized: affinity |
Medical Supply | Organogenesis Inc. | $25.44 | 1 | 2025 |
Source payment records
|
|||||
| HYDRO LEMAITRE VALVULOTOME Normalized: hydro lemaitre valvulotome |
Device | LeMaitre Vascular, Inc. | $25.07 | 1 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $21.87 | 1 | 2025 |
Source payment records
|
|||||
| Miro3D Normalized: miro3d |
Device | Reprise Biomedical, Inc. | $21.16 | 1 | 2025 |
Source payment records
|
|||||
| General - Angiography Normalized: general angiography |
Device | Boston Scientific Corporation | $20.94 | 1 | 2025 |
Source payment records
|
|||||
| VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP Normalized: vashe wound solution 250 ml 8 5 fl oz flip top cap |
Device | Urgo Medical North America, LLC | $20.34 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $19.58 | 1 | 2025 |
Source payment records
|
|||||
| OptiCross 35 Normalized: opticross 35 |
Device | Boston Scientific Corporation | $16.81 | 1 | 2025 |
Source payment records
|
|||||
| Varithena Administration Pack Normalized: varithena administration pack |
Device | Boston Scientific Corporation | $13.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 76 | 51 |
| Gabapentin | Gabapentin | 41 | 12 |
| Mupirocin | Mupirocin | 35 | 28 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | 11 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $54,317.75 · 90 records | Stryker Corporation | AFFINITY, AFX2 Bifurcated Endograft System, Asahi Peripheral Vascular Wires, Auryon Laser System 100-120 Vac, BioMimics 3D Vascular Stent System, CT THROMBECTOMY SYSTEM KIT, ENDOCROSS Device, ESPRIT, FLOWTRIEVER CATHETER, S, Flexitouch Plus, GRAFIX PL, General - Angiography, HYDRO LEMAITRE VALVULOTOME, Kerecis GraftGuide, Kerecis SurgiClose, LIMFLOW SYSTEM, MATRIDERM, MIRRAGEN ADVANCED WOUND MATRIX, Miro3D, NUZYRA, Nimbl, OptiCross 35, PELNAC Wound Matrix, PROCLAIM, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, RENASYS TOUCH, ROSEN, Restrata Wound Matrix, STRAVIX PL, Senza, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, TheraGenesis Wound Matrix, Torus Stent Graft System, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, Varithena Administration Pack, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error